INTRODUCTION
Understanding the mechanisms that regulate mucus hyperproduction and hypersecretion in respiratory diseases is critical for developing new therapeutic medications to use against inflammation. Although the importance of MUC5AC and MUC8 during airway inflammation has been emphasized in our previous studies, 1 -3 the negative regulatory mechanisms that can decrease their expressions in the airway remain unclear. Uncontrolled mucin hyperproduction and hypersecretion can increase morbidity and mortality by obstructing mucociliary clearance and air flow. 4 -6 Thus, clarification of the intracellular mechanism underlying the negative regulation of cytokine-induced MUC5AC overproduction could provide important clues toward understanding airway mucous hypersecretion.
c-E26 transformation-specific (Ets) 1 is a member of a family of transcription factors that have important roles in biological processes. 7 To date, more than 25 mammalian Ets family members have been characterized and are known to control important biological processes including cellular proliferation, differentiation, lymphocyte development, and activation, and transformation via the recognition of a GCA core sequence in the promoter or enhancer of target genes, and mutual regulation of the pro-and anti-inflammatory T H 1 response. 8 The probable dual function of c-Ets1 in the regulation of cellular phenomena has been suggested by the finding that c-Ets1 might be essential for the initiation and progression of T H 1-cell-mediated macrophages. This activation occurs by controlling the expression of several inflammatory cytokines / chemokines. 9 There are protein -protein interactions that are involved in every step of c-Ets1 inhibits the interaction of NF-B and CREB, and downregulates IL-1 -induced MUC5AC overproduction during airway inflammation 
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intracellular signaling, transcriptional transactivity regulation, and transcription factors turnover. 10 Therefore, we examined the role of c-Ets1 in a negative regulatory mechanism facilitated by disrupting the protein -protein (or transcription factor -transcription factor) interaction on the MUC5AC promoter.
Reactive oxygen species (ROS) are induced by proinflammatory cytokines such as interleukins and tumor necrosis factor, during atherosclerosis. 11 Superoxide anions are produced in vascular tissue by xanthine oxidases, cyclooxygenases, and NADPH oxidases (NOX). 12 NAD(P)H oxidases are the major sources of superoxide in vascular cells, and are essential in physiological responses and pathological states. The former includes cell growth, cell migration, and modification of the extracellular matrix, and the pathological states are associated with uncontrolled growth and inflammation, such as in atherosclerosis. 13 Until now, seven homologs of gp91 phox (NADPH oxidase; NOX2), the core component of NOX, have been identified in various nonphagocytic cells, including NOX1, NOX3, NOX4, NOX5, DUOX1, and DUOX2. 14 Of these, NOX4 is strongly expressed in endothelial cells. 15 Ushio-Fukai 16 showed that while ROS induces Ets-1 expression, the activated Ets-1 increases the expression of ROS-generating enzymes. The aims of this study were as follows: (1) To determine whether NF-B activation is involved in the nuclear signaling of IL-1 -induced MUC5AC gene expression, we performed Western blotting with several phospho-specific antibodies. Alterations were seen in the phosphorylation status of i B, NF-B, and cAMP response element-binding protein (CREB) after IL-1 treatment, but no expression changes were observed for NF-B, CREB, or CREB-binding protein (CBP) ( Figure 1a ) . As a result, we hypothesized that the interaction of NF-B with CREB may form a ternary complex with CBP and DNA to affect MUC5AC gene expression in IL-1 -induced signaling. To test our hypothesis, we performed an immunoprecipitation assay after the IL-1 treatment. CBP was able to bind to the NF-B after IL-1 treatment ( Figure 1b ) , resulting in the formation of CREB-CBP-NF-B to induce physiological phenomena. Interestingly, CREB was unable to bind to the NF-B regardless of IL-1 treatment ( Figure 1b 
We used the TFSEARCH Ver. 1.3 database ( http://www.cbrc. jp/research/db/TFSEARCH.html ) to identify the IL-1 -responsive cis -element in the MUC5AC promoter, and this search strategy identified a candidate, c-Ets1 (score = 91.2; threshold: 90.0). 9 To further investigate whether c-Ets1, which was found within the -938 / -930 region of the MUC5AC promoter, might act as a cis element, cotransfection with the − 950 / − 1 reporter construct and either wild-type c-Ets1 expression construct or siRNA-c-Ets1 construct was performed to determine its effect on MUC5AC transcription activity. Wild-type c-Ets1 did not affect the luciferase activity of − 950 / − 1 region of the MUC5AC promoter, whereas the siRNA-c-Ets1 increased the activity ( Figure 2b ). Moreover, we examined whether c-Ets1 acts as a suppressor. Three mutant constructs were generated to represent the selective mutagenesis of the c-Ets1-binding site. Only the − 938 mutant construct increased the responsiveness of the wild-type MUC5AC promoter construct ( Figure 2c ). However, the − 935 and -932 mutant constructs were able to suppress luciferase activity. These results suggest that the c-Ets1 ( − 938 / − 930 region) in the regulatory region of the MUC5AC promoter may be critical for IL-1 -induced suppression of MUC5AC transcriptional activity. We performed electrophoretic mobility shift assay experiments using nuclear extracts from NCI-H292 cells after IL-1 treatment to further determine whether c-Ets1 directly affects the IL-1 -induced interaction of CREB with the CRE of the MUC5AC promoter. 5 For electrophoretic mobility shift assay, oligonucleotides corresponding to CRE-specific sequences in the MUC5AC promoter region -878 to -871 (5 Ј -AGAGATTGC C TGACTTGA AGAGCTAG-3 Ј ) were synthesized. The activity of MUC5AC -specific CRE increased remarkably in response to IL-1 ( Figure 3c ). However, overexpressed c-Ets1 dissociated the interaction of CREB with the CRE site of the MUC5AC promoter, whereas siRNA-c-Ets1 did not have such an effect. To distinguish any specific CRE-binding complexes, competition analysis was performed using 50-fold excesses of non-radiolabeled (cold) CRE oligonucleotide. The specific band was selectively inhibited by the cold-CRE oligonucleotide, indicating that overexpressed c-Ets1 functions as a suppressor by disrupting the interaction of activated CREB with either a cis -acting element, CRE, or another transcription factor(s) in the MUC5AC promoter. Furthermore, to examine whether overexpressed c-Ets1 affects the interaction of NF-B with CREB to regulate IL-1 -induced MUC5AC gene expression, we performed an immunoprecipitation assay with anti-p65 IgG in c-Ets1-overexppressed cells ( Figure 3d ). Overexpressed c-Ets1 inhibited the interaction of CREB with NF-B after IL-1 treatment, whereas siRNAc-Ets1 did not affect the protein complex, indicating that c-Ets1 dissociated the CREB -NF-B complex to attenuate the IL-1 -induced physiological phenomena. These results are noteworthy 
because several reports have shown that c-Ets1 can bind to CBP / p300 but not to CREB. 17 -19 Thus, our results suggest that c-Ets1 may have a suppressive role in IL-1 -induced MUC5AC gene expression by negatively regulating the interaction of NF-B with CREB.
c-Ets1 inhibits IL-1 ␤ -induced mucous metaplasia, cell populations, and inflammatory proteins in mouse lungs
First, we examined whether the sh-c-Ets1 virus suppressed endogenous c-Ets1 protein levels. After viral infection into the right nostril of the mice, we verified that these viruses had wellexpressed coding proteins ( Figure 4a ). In order to investigate whether IL-1 -induced MUC5AC gene expression might be regulated by c-Ets1 in vivo as well as in vitro , tracheotomies were performed to instill IL-1 into either control or virus-infected mice. IL-1 -induced MUC5AC gene expression was dramatically decreased in the mice infected with the virus expressing wildtype c-Ets1 compared with those infected with the virus expressing sh-c-Ets1 ( Figure 4b ). Periodic acid-schiff (PAS) staining, which was achieved by inducing mucous metaplasia with IL-1 treatment in viruses-infected mice, was used to determine whether c-Ets1 acts as a negative regulator of the mucin granule exocytic complex during IL-1 -induced inflammation. The lungs from the infected mice were sectioned and stained with PAS. The airways of the IL-1 -instilled mice were found to be highly metaplastic, as they stained strongly with PAS ( Figure 4cii ). However, wild-type c-Ets1 overexpression inhibited IL-1 -induced mucous metaplasia ( Figure 4ciii ) whereas sh-RNA-cEts1 had no effect ( Figure 4civ ). Inflammation is characterized by infiltration of eosinophilic leukocytes and T-helper type 2 lymphocytes. 20 Eosinophils were the main constituent inflammatory cells in mice infected with viruses expressing either wildtype or shRNA-c-Ets1 that were treated with IL-1 . However, IL-1 -induced eosinophil production was not significantly higher in mice infected with virus expressing either wild-type or sh-RNA-c-Ets1 compared with wild-type mice (data not shown). Mice infected with virus-expressing sh-RNA-c-Ets1 had more lymphocytes, neutrophils, alveolar macrophages (AMs), and total protein levels in bronchoalveolar lavage (BAL) fluid, whereas those infected with virus expressing wild-type c-Ets1 had significantly decreased levels of such markers, compared with the IL-1 -instilled mice ( Figure 4d ). However, after IL-1 treatment, the total cell numbers peaked on day 7 in wild-type mice and declined until day 10. Moreover, to investigate the effect of c-Ets1 overexpression on modulation of inflammatory proteins after instillation of IL-1 , specific enzyme-linked immunosorbent assay (ELISA) kits were used ( Figure 4e ). The levels of inflammatory cytokines and the anti-inflammatory mediator, transforming growth factor (TGF)-1, in the first BAL fluid were analyzed 3 days after IL-1 treatment. c-Ets1 overexpression suppressed IL-1 -induced MIP2 and tumor necrosis factor (TNF)-production, whereas shRNA-c-Ets1 expression increased the production of these proteins. Interestingly, TGF-1 was increased in BAL fluid collected from the c-Ets-infected mice. These results show that c-Ets1 could reduce mucous metaplasia and inflammatory cell recruitment in BAL fluid after IL-1 treatment, suggesting that c-Ets1 functions as an important suppressor in IL-1 -induced inflammation in vivo .
ROS produced by NOX4 is essential for IL-1 ␤ -induced c-Ets1 gene expression in AMs
The c-Ets1 transcription factor induced cytokine and chemokine gene expression to regulate inflammation in Ets-1 knockout mice. 21 However, little is known about a role for ETS factors in regulating inflammation in AMs. Accordingly, we investigated whether c-Ets1 could regulate inflammatory cytokine gene expression in AMs. Mice were infected with viruses and killed 3 days post IL-1 instillation. The AM cells obtained via BAL of the lungs harvested from the killed mice were subsequently incubated. c-Ets1 overexpression inhibited expressions of the MIP2 and TNF-gene in AM cells, whereas shRNA-c-Ets1 increased the expression of these genes ( Figure 5a ). These results are consistent with those found for BAL fluid ( Figure 4e ). To examine whether IL-1 can produce ROS, flow cytometry 
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was used. ROS production was increased at 5 min and decreased at 10 min ( Figure 5b ). In addition, ROS production was unaffected AM cell viability ( Figure 5c ). To determine whether IL-1 induces a significant increase in the expression of NOX subtypes and to identify which NOX subtypes are involved in intracellular ROS production within AM cells, cells were treated with IL-1 in a time-dependent manner and real-time PCR was performed. Interestingly, only NOX4 gene expression increased significantly 20 min after IL-1 treatment ( Figure 5d ). We used siRNA -NOX4 to verify the function of NOX4. Expression of the c-Ets1 and Muc5ac gene was inhibited by siRNA -NOX4 ( Figure 5e ). These results suggest that NOX4 is not only a critical NOX homolog in AM cells in response to IL-1 , but also is essential for IL-1 -induced intracellular ROS generation and expressions of both c-Ets1 and Muc5ac gene.
DISCUSSION
This study was a detailed investigation of the negative regulation of the inflammation signaling mechanism, with special emphasis on the transcription factor c-Ets1. The in vitro and in vivo studies showed that c-Ets1 regulates MUC5AC overproduction through at least two different pathways. These pathways include functioning as an activator binding to CREB after adenosine triphosphate (ATP) treatment, and functioning as an attenuator. 9 , and lymphocytes, neutrophils, alveolar macrophages, and total protein levels in bronchoalveolar lavage (BAL) fluid were measured. * P < 0.05 compared with salinetreated mice and * * P < 0.05 compared with IL-1 -treated mice ( n = 4). ( e ) The levels of MIP-2, tumor necrosis factor (TNF)-, and transforming growth factor (TGF)-1 proteins in BAL fluid were measured using specific enzyme-linked immunosorbent assay kits. * P < 0.05 compared with saline-treated mice and * * P < 0.05 compared with IL-1 -treated mice ( n = 4).
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The transcription factor interactions affect the positive / negative regulation of the stimulant-induced expression of some genes. In our previous study, we found that the interaction of CREB with c-Ets1 resulted in ATP-induced MUC5AC gene expression, 9 suggesting that one or more transcription factor(s) are recruited by transcription factor complexes, because inflammatory conditions should increase stimulant-induced mucin gene expression. In fact, IL-1 can activate a number of transcriptional factors to induce many physiological phenomena. However, there are few studies of the negative regulation mechanism / signaling of mucous hypersecretion with respect to IL-1 -induced mucin gene expression. Understanding the biochemical properties of protein -protein interactions in the alteration of signal transduction should provide further understanding of biological phenomena as well as additional insight into the signal transduction leading to the regulation of intracellular signaling. It has been reported that either the NF-B or CREB signaling pathways are essential for IL-1 -induced MUC5AC overexpression in the airway. 5, 22 In this study, both pathways were found to function largely in MUC5AC overexpression by interacting with each other and sharing the signaling required for complementation and augmentation to be properly performed in the respiratory tract. Nevertheless, the reason for this interaction remains unclear and the mechanism underlying negative regulation has yet to be clarified. Determining the way in which MUC5AC overexpression is either downregulated or suppressed to maintain homeostasis may support the development of new therapeutic medication to control mucus overproduction. We, therefore, investigated a candidate protein for the downregulation of the interaction of NF-B with CREB in the airway.
Until now, there have been a number of reports on IL-1 -induced MUC5AC gene expression in the human airway. However, most of the studies on IL-1 have assumed it to be an upregulation mediator of inflammation when investigating intracellular signaling pathways. 23, 24 As many studies on the function of c-Ets1 in inflammation have focused on modulated physiological phenomena, 25, 26 the negative effect of c-Ets1 on cytokine-induced mucus hyperproduction and mucous hypersecretion during inflammation remains unclear. With the exception of our previous study, 9 there have been no reports on c-Ets1-regulated mucin overproduction in the airway. We speculated that IL-1 -induced c-Ets1 activation can function as an intracellular suppressor by inhibiting several transcription factors in the airway as well as inhibiting cancer cell proliferation by binding to p53. 27, 28 The most significant finding of this study is that c-Ets1 negatively regulated IL-1 -induced MUC5AC overexpression both in vitro and in vivo by dramatically disrupting the interaction of NF-B with CREB ( Figure 3d ). Previously, we reported that c-Ets1 functions as a co-activator of ATP-induced MUC5AC overexpression by binding to the ATP-activated CREB transcription factor in the airway. 9 Thus, we wondered if c-Ets1 has a dual function or if it recruits negative factors to abolish intracellular signaling. Our results show that c-Ets1 regulates the dynamics of the interaction between NF-B and CREB facilitated by IL-1 , which is supported by the finding that the c-Ets site ( − 930) is located very close to the NF-B site ( − 956) 29 and the CREB site ( − 878) 5 in the MUC5AC promoter. Accordingly, we hypothesized that c-Ets1 functions as an important suppressor of IL-1 -induced MUC5AC overproduction, at least in part, in the airway epithelium. However, we found that binding of CREB to c-Ets1 for ATP signaling enhanced MUC5AC gene expression in NCI-H292 cells. 9 This discrepancy may be due to (1) secondary effects of signaling for c-Ets1 activation at the receptor level; (2) c-Ets1 functioning as a signaling conductor; or (3) differences in the type of stimuli because signal transduction may rely heavily on the interaction of stimulants with their own receptors or molecules. These conjectures indicate that even c-Ets1 with transient signaling capability may act as a signaling molecule by The AM cells from saline-treated mice were pre-incubated in the presence of 50 μ M 2 Ј ,7 Ј -dichlorofluorescein diacetate for 30 min, and then exposed to IL-1 (20 ng ml − 1 ) for the indicated periods. Cell-associated 2 Ј ,7 Ј -dichlorofluorescein levels were analyzed by flow cytometry. * P < 0.05 compared with saline-treated mice ( n = 4). ( c ) The AM cells from salinetreated mice were pre-incubated in the presence of N-acetyl-cysteine for 1 h in a dose-dependent manner, and then treated with IL-1 (20 ng ml − 1 ) for 1 h. A cell proliferation assay was performed with CCK-8 (Dojindo, Rockville, MD) ( n = 4). ( d ) The AM cells from saline-treated mice ( n = 4) were exposed to IL-1 (20 ng ml − 1 ) for the indicated times, and then were performed RT-PCR with specific primers. 38 ( e ) The AM cells from saline-treated mice ( n = 4) were transiently transfected with either the small interfering RNA (siRNA) construct of NOX4 or a siRNA control. Cells were treated with IL-1 (20 ng ml − 1 ) for 24 h, and RT-PCR was subsequently performed. Representative results for more than three independent experiments are shown for each group.
amplifying the signal, thus producing the correlated physiological phenomena. Additionally, we suppose that activated c-Ets1 may regulate the dynamics of the interaction between CREB and NF-B, thereby negatively regulating mucous overproduction. Our hypothesis is supported by the finding that c-Ets1 can bind to other transcription factors, such as AP-1, NF-B, and the Pax family, in response to diverse signals. 10 However, the main difference between our findings and those previously reported in the literature is that we observed that c-Ets1 dissociated the interacted NF-B and CREB, thereby dissociating the protein complex to regulate mucus overproduction during airway inflammation.
More interestingly, c-Ets1 functioned as a negative regulator in vivo in the mouse lung model ( Figure 4b ). We used mouse lungs, but not tracheas, to detect morphological differences largely in Muc5ac overproduction. We had difficulty detecting such differences using mouse tracheas after lipopolysaccharide instillation because the differences between the sham mice and the challenged mice were undetectable. 1 One possible reason for this finding was that the activator solution may have passed through the trachea without affecting mucus expression in the mouse tracheas. Thus, in the present study, lungs were selected in order to detect more dramatic morphological changes. Interestingly, IL-1 -induced mucous metaplasia, neutrophils, and AMs were decreased by c-Ets1, whereas shRNA-c-Ets1 increased mucous metaplasia, suggesting that c-Ets1 functions as a negative regulator to maintain homeostasis by disrupting the interaction of NF-B with CREB in vivo . However, it is still unclear whether c-Ets1 has consequences for IL-1 -induced mucous metaplasia and Muc5ac overproduction. Based on the results of our previous study 9 and the present study, c-Ets1 may influence physiological phenomena according to its role as a suppressor or activator in intracellular signaling. Even though such a result provides insight into the regulatory mechanism of mucus hyperproduction, an understanding of how c-Ets1 can regulate the amount of total protein, AMs, and neutrophils in BAL fluid is still unclear. In addition, if c-Ets1 functions in BAL fluid as well as in vivo , it may be related to apoptotic cell clearance in acute lung injuries. 30 NOX4 is expressed predominantly in goblet cells in normal human nasal epithelial cells and might function in the induction of the expressions of both MUC5AC and MUC8 gene. 31, 32 In addition, Lee et al. 33 reported that NOX4 was expressed in human monocytes and mature macrophages. ROS activates the JAK -STAT pathway, which in turn contributes to goblet cell metaplasia, a major player in mucin production and airway clogging. 34 Recently, Severgnini et al. 35 showed that ROS regulates STAT activation in acute lung injuries. The importance of NOX4 for mucus hyperproduction and mucous hypersecretion is becoming increasingly apparent. In this study, we showed that siRNA -NOX4 decreased c-Ets1 and Muc5ac gene expression in AM cells ( Figure 5e ), suggesting that NOX may have critical functions in airway inflammation and may regulate ROS production to maintain homeostasis in the airway.
Although MUC5AC was mainly expressed in epithelial cells and goblet cells, we found that lipopolysaccharide could induce Figures 3b and 4b ) , there are three potential reasons for the induced expression of these genes, which have either an inflammatory function or a suppressive function. First, when inflammation is severe in the airway, suppressor proteins are overexpressed and inhibit mucus hyperproduction through c-Ets1 ' s inhibitory function. Second, IL-1 induces more active MUC5AC gene expression than c-Ets1 in order to increase mucus hyperproduction in inflammatory conditions. Third, IL-1 can induce production of the same levels of these proteins; however, some protein(s) abolish c-Ets1 gene expression. We assert that cells can regulate the balance between the production of these proteins to maintain homeostasis.
In conclusion, we found that the interaction of NF-B with CREB enhanced IL-1 -induced MUC5AC overproduction and the effect of the interaction was mutually additive. In addition, our findings showed that c-Ets1 could negatively regulate MUC5AC overproduction by inhibiting the protein -protein interaction both in vitro and in vivo , indicating that c-Ets1 induces the reduction of mucous metaplasia, the number of AMs and neutrophils, and decreases MUC5AC overproduction. Moreover, ROS produced by NOX4 may transfer the signal to alter the inflammatory process in vivo . Thus, these results suggest that c-Ets1 may be a potential therapeutic candidate to treat mucus hyperproduction by inhibiting the protein -protein interactions involved in MUC5AC overproduction.
